高级检索
当前位置: 首页 > 详情页

The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Jianghan Univ, Gerontol Res Ctr, Hosp Wuhan 6, Affiliated Hosp, Wuhan, Peoples R China [2]Jianghan Univ, Sch Med, Wuhan Inst Biomed Sci, Wuhan, Peoples R China [3]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pharm, Wuhan, Peoples R China
出处:
ISSN:

关键词: Benign prostatic hyperplasia Stromal cells Epithelial cells Exosome-like vesicles Epithelial-mesenchymal transition

摘要:
Benign prostatic hyperplasia (BPH) is an age-related disease in men. Mesenchymal /stromal and epithelial cells interactions are essential to prostate functions. In this study, human nonmalignant prostate epithelial RWPE-1 cells were cocultured with testosterone (TE) -exposed prostate stromal fibroblasts WPMY-1 cells (TE-WPMY-1). The survival rate, epithelial-mesenchymal transition (EMT) and collagen deposition of RWPE-1 were observed. The expression profiles of circRNAs, lncRNAs and mRNAs in WPMY-1-derived exosome-like vesicles (WPMY-1-exo) were explored by high-throughput RNA sequencing. Firstly, both TE-WPMY-1 and TE-WPMY-1-exo significantly promoted RWPE-1 cells proliferation. Secondly, 41 circRNAs, 132 lncRNAs and 1057 mRNAs were differentially expressed (DE) between TE-WPMY-1-exo and the control. Functional enrichment analyses, coexpression analyses and quantitative real-time PCR verification showed that the DE RNAs played important roles in cell proliferation, structure, phenotype and fibrosis. Lastly, blocking WPMY-1-exo biogenesis/release by GW4869 can attenuate TE-WPMY-1-stimulated RWPE-1 cells EMT and collagen deposition. Taken together, our results indicated that WPMY-1-exo modulated the phenotypes changes and collagen deposition of prostate epithelial cells. It provided a novel basis for understanding the underlying mechanisms of RWPE-1 cells EMT and fibrosis induced by WPMY-1 in BPH.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 2 区 药学 2 区 毒理学
最新[2025]版:
大类 | 3 区 医学
小类 | 2 区 毒理学 3 区 药学
JCR分区:
出版当年[2019]版:
Q2 PHARMACOLOGY & PHARMACY Q2 TOXICOLOGY
最新[2023]版:
Q2 PHARMACOLOGY & PHARMACY Q2 TOXICOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Jianghan Univ, Gerontol Res Ctr, Hosp Wuhan 6, Affiliated Hosp, Wuhan, Peoples R China [2]Jianghan Univ, Sch Med, Wuhan Inst Biomed Sci, Wuhan, Peoples R China
通讯作者:
通讯机构: [1]Jianghan Univ, Gerontol Res Ctr, Hosp Wuhan 6, Affiliated Hosp, Wuhan, Peoples R China [2]Jianghan Univ, Sch Med, Wuhan Inst Biomed Sci, Wuhan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:2 总访问量:410 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)